Medicare beneficiaries who schedule a screening colonoscopy expect to pay nothing out of pocket. That expectation is correct, but only up to a point. When a doctor discovers and removes a polyp during the same procedure, the visit can be reclassified from screening to diagnostic or therapeutic, and the patient suddenly owes coinsurance. The billing shift catches many people off guard, turning what they believed was a free preventive test into an unexpected medical bill.
How a free screening colonoscopy becomes a billable procedure
Medicare Part B covers screening colonoscopies, and beneficiaries generally pay $0 when the provider accepts assignment, according to Medicare rules. The zero-cost promise applies to the screening itself. Once a physician identifies a polyp or abnormal tissue and decides to remove it during the same session, the procedure crosses a billing threshold. At that point, the patient owes coinsurance for the additional work performed.
The gap between patient expectations and actual billing traces back to how claims are coded. CMS billing guidance in Article A55069 directs coders to append the PT modifier when unanticipated pathology during a screening colonoscopy requires intervention. That modifier signals to Medicare that the visit started as a screening but converted to a diagnostic or therapeutic procedure. The conversion triggers cost-sharing that would not apply to a routine screening alone.
The distinction matters because polyp removal is common. Physicians performing colonoscopies on older adults frequently find and remove polyps in the same session, which is considered standard clinical practice. Patients rarely know in advance whether they will have a polyp, so the financial consequence is difficult to anticipate before the procedure begins.
CMS transmittal and insurer reclassification practices
CMS has addressed the coinsurance question through policy updates. One operational transmittal outlines changes to beneficiary cost-sharing for additional procedures furnished during the same clinical encounter as certain colorectal cancer screening tests. The intent is to clarify how coinsurance should be calculated when a screening colonoscopy leads to unplanned additional work, such as biopsy or polyp removal, in a single visit. However, details about how consistently these rules are applied in practice, and how closely contractors monitor compliance, are not fully transparent to patients.
The problem extends beyond Medicare’s own rules. The National Cancer Institute notes that some insurers treat a screening colonoscopy that finds a polyp requiring removal as diagnostic and charge accordingly. This means the billing reclassification is not unique to Medicare. Private insurers and Medicare Advantage plans can apply similar logic, leaving beneficiaries across coverage types exposed to the same surprise.
Uneven communication and patient confusion
Patients often learn about the possibility of coinsurance only after they receive a bill. Pre-procedure paperwork may mention that additional services could generate charges, but the language is typically buried in dense consent forms or financial disclosures. Many beneficiaries focus on the widely publicized message that preventive screenings are covered in full and do not realize that a single procedure can shift categories midstream.
Clinicians, for their part, generally prioritize medical best practices over billing nuances. When they see a suspicious polyp, the standard of care is to remove it immediately rather than schedule a separate visit. While this approach protects patients medically, it increases the likelihood that a “no-cost” screening will become a partially billable diagnostic procedure. Few gastroenterologists have time during a pre-procedure consultation to explain every potential billing scenario, especially when the presence of polyps cannot be predicted.
This communication gap leaves beneficiaries with the impression that something has gone wrong when the bill arrives. In reality, the claim may have been processed exactly as current policy allows. The disconnect lies in how those policies are explained before the procedure and how little control patients have once they are sedated and the physician must make real-time decisions.
What patients can do before a colonoscopy
Beneficiaries cannot eliminate the risk of coinsurance entirely, but they can take steps to reduce surprises. Calling the endoscopy center and asking whether the physician and facility accept Medicare assignment is a basic starting point. Patients can also ask directly how the practice bills when a screening colonoscopy leads to polyp removal in the same session, and whether the PT modifier is used to indicate that the visit began as a screening.
It is also important to confirm coverage details with the insurer, whether that is traditional Medicare, a Medicare Advantage plan, or an employer-sponsored policy. Members can ask whether a colonoscopy that starts as a screening but includes biopsy or polypectomy will be subject to coinsurance or a deductible. While front-line customer service representatives may not anticipate every scenario, documenting the conversation and keeping any written benefit explanations can help if a bill is later disputed.
Policy debates and the road ahead
Advocates argue that cost-sharing for polyp removal undermines the public health goal of promoting colorectal cancer screening. If beneficiaries fear unexpected bills, they may delay or avoid colonoscopies altogether, despite strong evidence that early detection and removal of precancerous lesions saves lives. Some policy proposals have called for eliminating coinsurance when a screening colonoscopy converts to a diagnostic procedure in the same session, effectively treating the entire encounter as preventive.
For now, though, the rules around screening and diagnostic colonoscopies remain complex, and patients bear the burden of navigating them. Understanding how coding modifiers, insurer policies, and clinical decisions intersect can help beneficiaries prepare for both the medical and financial aspects of this common procedure. Clearer communication from providers and insurers may not change the underlying billing rules, but it can at least ensure that a “free” screening does not feel like a broken promise when the explanation of benefits arrives.
Free for readers: The free Retirement Shield newsletter sends plain-English help keeping more of your money in retirement — the scams to dodge, the benefits you’re owed, and what’s changing with Social Security and Medicare, a couple times a week. Get the free newsletter.
